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BACKGROUND: Oral lichen planus (OLP) is known to be a 
chronic inflammatory disease associated with various other 
systemic disorders. Studies have shown that vitamin D deficiency 
can be involved in the pathogenesis of lichen planus. The aim of 
this study was to investigate the role of vitamin D and vitamin D 
receptor in OLP. 
METHODS: In this review study, all English and Persian articles 
were searched by relevant keywords from the Google scholar, 
PubMed, science direct, Cochrane, Scopus and Sid databases 
until January 2020.  
RESULTS: From the 16 articles obtained after reviewing the 
abstracts, finally 14 appropriate articles were included in this 
study. 
CONCLUSION: According to the results of the studies, vitamin D 
deficiency may be associated with an increased risk of OLP 
lesions. 




Lichenoid reactions represent a family of lesions with different 
etiologies with a common clinical and histologic appearance. Oral 
lichenoid reactions include the following disorders: Oral lichen 
planus (OLP), Lichenoid contact reactions, Lichenoid drug 
eruptions and Lichenoid reactions of graft-versus-host disease 
(GVHD) (1).  OLP is known to be a chronic inflammatory disease 
associated with various other systemic disorders (2). It often 
involves middle-aged patients and is more common in women than 
in men (3). OLP is commonly seen as symmetrical and bilateral 
lesions with multifocal involvement in the oral mucosa (4). The 
etiology of the disease is not yet well understood. In different 
systemic conditions and various autoimmune diseases and under the 
use of drugs and exposed to a number of substances and infections, 
lesions similar to lichen planus occur, but the exact relationship 
between all these factors and the cause of the lesion has not been 
determined yet (5). An important issue with this disease is the  
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possibility of malignant changes. This has been 
the subject of debate for many years. Although 
extensive research has been done in this area, it 
is still doubtful whether the lesion is benign or 
susceptible to malignancy. OLP has various 
clinical appearances, which can occur in 
different places of the mouth, can be 
uncomfortable or accompanied by burning and 
pain and may show periods of recurrence and 
recover. This variation in clinical appearance 
can make diagnosis difficult (6). 
Vitamin D is a fat-soluble vitamin that has 
two internal and external sources (7,8). 
Although until two decades ago, there was no 
conception of the relationship between vitamin 
D and the immune system; increasing studies in 
recent years suggest that this vitamin's role in 
the immune system is widespread. Vitamin D 
receptors (VDR) are abundantly present in T 
lymphocytes and macrophages and most 
commonly in immature thymic immune cells 
and mature TCD8 + lymphocytes (9-11). 
Different forms of Vitamin D can play a role in 
suppressing of autoimmune diseases in animal 
models. In this regard, the results of studies 
indicated that 1 and 25 -Hydroxyvitamin D3 can 
prevent or suppress the manifestation of 
experimental autoimmune encephalomyelitis, 
rheumatoid arthritis, systemic lupus 
erythematous, diabetes, and inflammatory bowel 
disease (12,13). The mechanism of these 
suppressive effects against autoimmune diseases 
has also been suggested that vitamin D causes 
production of interleukin-4 (IL-4) and 
Transforming growth factor-beta (TGFB-1) 
which suppresses T-cell inflammatory activities. 
Vitamin D deficiency in the immune system 
reduces T helper 2 (Th2) levels and other cells 
involved in the inflammatory pathway such as 
Th1 and Th17 (14).  
In recent years, numerous studies have been 
conducted on the role of vitamin D in the 
prevention of OLP. Studies have shown that 
vitamin D inhibits the production of interferon 
gamma (IFN-γ) and IL-1β in the epithelium and 
its deficiency may be involved in the 
pathogenesis of OLP (15-18). Epidemiologic 
studies showed that conflicting results regarding 
the serum levels of vitamin D and the role of this 
vitamin and its receptors in the development of 
OLP. In some of these studies, no significant 
difference was found between serum vitamin D 
levels and healthy controls, and in other studies, 
vitamin D deficiency was found in individuals 
with OLP compared to healthy controls (15-18). 
In this study, we aim to systematically 
investigate the role of vitamin D and its receptor 
in OLP. Identification of this role in OLP might 
be useful for development of new preventive and 




Search strategy: This systematic review was 
conducted based on the Preferred Reporting 
Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement for reporting sys-
tematic reviews (19).  
In this review study, all published English 
and Persian articles with the keywords of "oral 
lichen planus" and "vitamin D receptor" or 
"VDR" and "vitamin D" and their Persian 
equivalents from Google scholar, PubMed, 
Science Direct, Cochrane, Scopus and Sid 
databases were searched until January 2020. In 
the initial phase, the titles and abstracts of the 
articles were reviewed by two independent 
individuals based on the inclusion and exclusion 
criteria. Disagreements were resolved with the 
third author’s discussion. Next, the full text of 
the selected articles was reviewed. The quality 
of the studies was evaluated by the Newcastle-
Ottawa scale method (20). The data of selected 
articles were extracted using data extraction 
form. This form includes the author's name/year 
of publication/sample size and the results of the 
studies. 
Inclusion criteria: The inclusion criteria are the 
studies that 1) have evaluated serum levels of 
vitamin D in patients with active phase of OLP 
who have recently been diagnosed with the 
disease and did not previously received 
medication for OLP; 2) have examined the effect 
of vitamin D on OLP; 3) have investigated VDR 
gene polymorphism in patients with OLP and 4) 
have investigated the mechanisms of creating 
OLP due to Vitamin D or VDR Deficiency.  
Exclusion criteria: The review and case reports 
articles and studies that have investigated the 
role of vitamin D or its receptor in patients with 
cutaneous lichen planus were excluded.  
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Statistical analyses: The analyses were done by 
Review Manager 5.3 (Rev- Man 5.3, the 
Cochrane Collaboration, Oxford, UK) with a 
random-effects model using mean difference 
(MD) and 95% confidence intervals (CIs). The 
heterogeneity percentage between the studies 
was evaluated by the Cochrane Q test and I2 
statistic; if I2 > 50%, there was a heterogeneity. 







Initial searches of 106 articles were extracted. 
From the 16 articles obtained after reviewing the 
abstracts, finally 14 appropriate articles were 
included in this study based on the entry and exit 
criteria shown in Figure 1. Of the 14 articles 
selected, 4 studies examined serum levels of 
vitamin D in affected individuals (17,18,21,22), 
2 studies studied the effect of vitamin D 
supplementation on OLP symptoms (23,24), in 2 
studies, the association of VDR gene 
polymorphisms and OLP risk have been 
investigated (25,26) and 6 studies have 
investigated the mechanisms of OLP formation 
due to vitamin D deficiency (27-32) (Table 1). 
 
 
Figure 1: The flowchart of searching strategy based on PRISMA guidelines 
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Table 1: summary of the data extracted from included studies in this review 
 
Studies groups Authors Results 
A: Studies that 
have evaluated 
serum levels of 
vitamin D in 
patient with OLP 
 
Gupta et al/ 
2017 (21) 
102 patients with OLP and 102 healthy subjects were included in study. Vitamin D in 
the cases of OLP and control was 20.40 ng / ml and 32.67 ng / ml, respectively. This 




20 patients with OLP and 20 healthy subjects were included in study. Statistically 
significant difference was seen in vitamin D level of serum between healthy subjects 
and patients with OLP (P <0.05) 
Bahramiyan 
et al / 2018 
(17) 
18 patients with OLP and 18 healthy subjects were included in study. The mean 
vitamin D level in serum of patients with OLP was 30.38 + 20.38 ng / ml and in healthy 
subjects 36.45 + 15.33 ng / ml, there was no statistically significant difference. (P = 
0.34) 
Seif et al 
/2018 (22) 
30 patients with OLP and 66 healthy subjects were included in study. Serum vitamin D 
levels are decreased in a high percentage of patients with OLP. 
B: Studies that 
have evaluated 





Razi et al/ 
2018 (23) 
 100 women in premenopausal period with vitamin D serum level below 30 ng/ml 
divided into 2 groups: group A which received routine treatment and group B which 
received routine treatment + vitamin D supplement. Their results showed Subjects in 
group B shows improvement in clinical appearance of lesion between week 1 and week 
4.  
Gupta et al 
/2019 (24) 
106 patients with OLP divided to 3 groups: group 1 received topical steroid treatment 
with psychological counseling, group 2 received topical steroids with vitamin D 
supplementation and group 3 received topical steroids with vitamin D supplementation 
and psychiatric consultation. Their results showed a statistically significant 
improvement in symptoms (mentally and objectively) in patients receiving vitamin D 
supplementation. 








et al /2016 
(25) 
VDRFokI rs2228570 gene polymorphism significantly increased OLP risk in allelic, 
genotypic and dominant models, which was not significant for VDR EcoRV 
rs4516035, VDRApaI rs7975232 and VDRTaqI rs731236 polymorphisms. 
Shen et al/ 
2020 (26)  
VDR rs2239185 polymorphism in TT and recessive genotypes and VDR rs7975232 




OLP lesions due 
to vitamin D or 
VDR deficiency 
 
Du et al 
/2017 (27) 
Vitamin D and its associated VDR have an anti-inflammatory role in OLP through 
regulation of the nuclear factor-κB (NF-κB) pathway. VDR expression is reduced in 
Th1-mediated diseases. 
Zhao et al/ 
2018 (28) 
Lipopolysaccharides (LPS) decrease VDR through the tumor necrosis factor alpha 
(TNFα) - miR-346 pathway. Vitamin D / VDR signaling suppresses LPS-induced p53-
upregulated modulator of apoptosis (PUMA) via NF-κB pathway blockade, thereby 
reducing apoptosis of epithelial cells 
Zhao et al 
/2019 
(29) 
Vitamin D / VDR signaling suppresses LPS-induced hypoxia-inducible factor-1α (HIF-
1α) via the NF-κB pathway block, thereby reducing the production of IFN γ and IL-1β. 
Ge et al/ 
2019 (30) 
Vitamin D / VDR signaling inhibits miR-802 expression by regulating the NF-κB 
pathway, thereby reducing apoptosis of epithelial cells. miR-802 Increases Bcl-2 
Expression (Bcl-2) and Induces Apoptosis of Epithelial Cells 
Ge et al/ 
2020 (31) 
MicroRNA-27a / b significantly decreased in serum, saliva and OLP tissue samples. 
They showed that there are sites for VDR binding in the promoter region of the 
MicroRNA-27a / b gene and that Vitamin D / VDR signaling induces MicroRNA-27a / 
b in OLP. 
Du et al/ 
2020 (32) 
MicroRNA-26a / b significantly decreased in serum, saliva and OLP tissue samples. 
They showed that there are sites for VDR binding in the promoter region of the 
MicroRNA-26a / b gene and that Vitamin D / VDR signaling induces MicroRNA-26a / 
b in OLP. MicroRNA-26a / b has a protective role in OLP through inhibition of 
apoptosis and reduction of pro-inflammatory cytokines in epithelial cells. 
 
Serum vitamin D levels: Figure 2 shows the 
forest diagrams of the meta-analysis. Four 
studies were included in the meta-analysis. In 
the OLP and control groups, 206 and 170 
patients were studied, respectively. There were 
166 patients with OLP and 104 controls with 
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vitamin D less than 30 ng/ml. Heterogeneity 
between studies was not significant (Q = 5.57, df 
= 3, I2 = 46.19, p-value = 0.13). According to 
the results of the meta-analysis, the odds of 
vitamin D levels in patients with OLP being 
lower than 30 ng/ml were 2.65 times higher than 
those in the control group (OR = 2.65.95% CI = 
1.20 - 5.83, p-value = 0.015).  
The effect of vitamin D supplementation on 
OLP symptoms: Studies that have evaluated the 
effect of vitamin D supplementation on OLP 
showed statistically significant improvement in 
symptoms of OLP patients receiving vitamin D 
supplementation.  
Association of VDR and OLP Gene 
Polymorphisms: As a ligand-dependent 
transcription factor, vitamin D receptors 
encoded by the VDR gene (chromosomal locus 
14-12q12) play important roles in regulating the 
role of vitamin D (33). Significant differences in 
allelic distribution and genotype of VDR FokI 
polymorphism (rs2228570) between OLP 
patients and control group indicated the possible 
importance of VDR FokI polymorphism in 
susceptibility to OLP. The single nucleotide 
polymorphisms are rs2239185 and rs7975232 in 
the intron region of the VDR gene (34). The 
GTEX database has shown that the amount of 
VDR expression in the blood is actually affected 
by genetic changes. Thus, polymorphisms in 
VDR genes may affect the expression of blood 
VDR and decrease the binding of vitamin D to 
VDR in blood and oral keratinocytes and 
prevent activation of the VD/VDR pathway (29). 
Such anti-inflammatory effects are inhibited and 
eventually lead to lichen planus. In two studies 
by Kujundzic et al (25) and Shen et al (26) on 
the polymorphism of the rs7975232 VDR gene, 
different results were presented. It is noteworthy 
that the different results may be due to different 
ethnic populations and sample sizes. 
Pathways of creating OLP due to Vitamin D 
or VDR Deficiency: Schematic illustration of 
mediatory effect of vitamin D/VDR signaling on 
prevention of OLP is shown in Figure 3. 
 
 
 Figure 2: Forest diagrams from the meta-analysis 
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In the present study, the role of vitamin D and 
VDR in OLP was investigated. The results of 
this review study showed that vitamin D 
deficiency was present in a higher percentage of 
patients with OLP, and that the use of vitamin D 
supplements caused a significant improvement 
in these patients. Various properties of vitamin 
D have been investigated for its effects in 
different types of diseases. In addition, the 
effects of vitamin D can be affected by the 
presence of single nucleotide polymorphisms in 
vitamin D-related genes, such as the VDR and 
cytochrome P450 genes that are involved in 
vitamin D metabolism. 
Because OLP is considered a potential 
precancerous lesion, single nucleotide 
polymorphisms (SNPs) in VDR or vitamin D 
pathway genes may also play important roles in 
oral cancer. Hormones 1 and 25 -
Hydroxyvitamin D3 induce VDR receptor 
expression in epithelial cells and act as a 
mucosal barrier. The VDR receptor protects 
against invasion of microbes into the underlying 
connective tissue, and in the case of the oral 
lichen planus, epithelial destruction means 
apoptosis or planned cell death (15). Vitamin D 
deficiency results in impaired T cell 
proliferation and may therefore lead to the 
development of OLP. The conclusion from 
Figure 3 is that inflammation and bacterial 
lipopolysaccharides activate pro-inflammatory 
cytokines and produce factors that induce 
apoptosis of keratinocytes and the formation of 
OLP lesions. Chinese researchers have found 
that vitamin D/VDR signaling inhibits the NF-
κB pathway and also increases the production of 
MicroRNA-26, 27 a/b. As a result, apoptosis of 
epithelial cells and the possibility of OLP lesions 
are reduced (27-32). 
In developed or developing countries, 
vitamin D insufficiency or deficiency among the 
general population has been the focus of much 
research. This may be due to a variety of 
reasons, including increased use of sunscreen, 
increased indoor activity, and more skin 
coverage due to different cultural beliefs and 
religious practices or protection against skin 
cancer. The conclusion to be drawn from this 
study is that vitamin D deficiency may be 
associated with an increased risk of developing 
OLP lesions. It is hoped that this study will raise 
our awareness of the role of vitamin D and its 
receptor in OLP lesions and open new avenues 
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